Literature DB >> 2996660

Quantitation of adenosine-5'-triphosphate used for phosphoinositide metabolism in human erythrocytes.

G L Dale.   

Abstract

The human erythrocyte actively phosphorylates and dephosphorylates phosphatidylinositol present in the membrane in an apparent "futile cycle." Recent reports have proposed that this phosphorylation/dephosphorylation cycle is a significant consumer of adenosine-5'-triphosphate (ATP) in the erythrocyte. This study details two independent techniques for quantitating the ATP consumed by this phosphoinositide futile cycle. With the first technique a quasi-steady-state labeling of erythrocyte ATP with 32P-phosphate was obtained, and the rate of synthesis of 32P-phosphoinositides was then monitored. The second technique used a novel labeling strategy that allowed only ATP to be labeled with 32P; the transfer of 32P from ATP to phosphoinositides was then an independent measure of the ATP consumed for phosphoinositide synthesis. These two techniques documented that 0.5% to 1.0% of net ATP produced by the erythrocyte is used for phosphoinositide synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996660

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Multiple metabolic pools of phosphoinositides and phosphatidate in human erythrocytes incubated in a medium that permits rapid transmembrane exchange of phosphate.

Authors:  C E King; L R Stephens; P T Hawkins; G R Guy; R H Michell
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

2.  Determination of the steady-state turnover rates of the metabolically active pools of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate in human erythrocytes.

Authors:  C E King; P T Hawkins; L R Stephens; R H Michell
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

Review 3.  Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: insights from vesicle recycling in nerve terminals.

Authors:  Markus R Wenk; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-14       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.